OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

μ-Opioid Receptor Forms a Functional Heterodimer With Cannabinoid CB1 Receptor: Electrophysiological and FRET Assay Analysis
Minoru Hojo, Yuka Sudo, Yukio Ando, et al.
Journal of Pharmacological Sciences (2008) Vol. 108, Iss. 3, pp. 308-319
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
Ream Al‐Hasani, Michael R. Bruchas
Anesthesiology (2011) Vol. 115, Iss. 6, pp. 1363-1381
Open Access | Times Cited: 894

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 2, pp. 234-243
Open Access | Times Cited: 455

Signal transduction of the CB1 cannabinoid receptor
Gábor Turu, László Hunyady
Journal of Molecular Endocrinology (2009) Vol. 44, Iss. 2, pp. 75-85
Open Access | Times Cited: 305

CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets‐Garcia, Jaideep S. Bains, Giovanni Marsicano
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 4-20
Open Access | Times Cited: 278

G Protein–Coupled Receptor Heteromers
Ivone Gomes, Mohammed Akli Ayoub, Wakako Fujita, et al.
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 403-425
Open Access | Times Cited: 247

Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucía Callén, Estefanía Moreno, Pedro Barroso‐Chinea, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 25, pp. 20851-20865
Open Access | Times Cited: 214

Diversity of molecular targets and signaling pathways for CBD
Douglas Lamounier de Almeida, Lakshmi A. Devi
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 6
Open Access | Times Cited: 192

Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
Jillian L. Scavone, Robert C. Sterling, Elisabeth J. Van Bockstaele
Neuroscience (2013) Vol. 248, pp. 637-654
Open Access | Times Cited: 185

An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100

Consequences of Perinatal Cannabis Exposure
Andrew F. Scheyer, Miriam Melis, Viviana Trezza, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 871-884
Open Access | Times Cited: 93

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Suzanne Nielsen, Louisa Picco, Bridin Murnion, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1315-1330
Open Access | Times Cited: 56

Cannabinoid CB1 receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Tricia H. Smith, Laura J. Sim‐Selley, Dana E. Selley
British Journal of Pharmacology (2010) Vol. 160, Iss. 3, pp. 454-466
Open Access | Times Cited: 116

Neurochemical basis of cannabis addiction
Rafaël Maldonado, Fernando Berrendero, Andrés Ozaita, et al.
Neuroscience (2011) Vol. 181, pp. 1-17
Closed Access | Times Cited: 104

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
Kathryn A. Seely, Lisa K. Brents, Lirit N. Franks, et al.
Neuropharmacology (2012) Vol. 63, Iss. 5, pp. 905-915
Open Access | Times Cited: 96

Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91

Opioids and Neuropathic Pain
Howard S. Smith
Pain Physician (2012) Vol. 3S;15, Iss. 3S;7, pp. ES93-ES110
Open Access | Times Cited: 86

Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR Review 10
Wakako Fujita, Ivone Gomes, Lakshmi A. Devi
British Journal of Pharmacology (2014) Vol. 171, Iss. 18, pp. 4155-4176
Open Access | Times Cited: 81

Bivalent Ligands That Target μ Opioid (MOP) and Cannabinoid1 (CB1) Receptors Are Potent Analgesics Devoid of Tolerance
Morgan Le Naour, Eyüp Akgün, Ajay Yekkirala, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 13, pp. 5505-5513
Open Access | Times Cited: 78

Opioid receptor heteromers in analgesia
Cristina M. Costantino, Ivone Gomes, Steven D. Stockton, et al.
Expert Reviews in Molecular Medicine (2012) Vol. 14
Open Access | Times Cited: 78

Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play
Antonia Manduca, Olivier Lassalle, Marja D. Sepers, et al.
Frontiers in Behavioral Neuroscience (2016) Vol. 10
Open Access | Times Cited: 64

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29

Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28

Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
Jillian L. Scavone, Ken Mackie, Elisabeth J. Van Bockstaele
Brain Research (2009) Vol. 1312, pp. 18-31
Open Access | Times Cited: 84

Functional characterization of human variants of the mu-opioid receptor gene
Ajay Ravindranathan, Geoff Joslyn, Margaret Robertson, et al.
Proceedings of the National Academy of Sciences (2009) Vol. 106, Iss. 26, pp. 10811-10816
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top